Dr. Nicole Schneiderhan-Marra

Dr. Nicole Schneiderhan-Marra studied biochemistry at the Eberhard Karls University in Tübingen. Her subsequent doctoral thesis was. She also received her doctorate in Tübingen. The practical work of the external doctoral thesis to the Dr. rer. nat. took place in the Medical Clinic IV, Nephrological Research Laboratories, and at the Friedrich-Alexander-University Erlangen-Nuremberg Dr. Schneiderhan-Marra's main focus is on the development, validation and application of antigen arrays and multiplex serological immunoassays for pathogen infection diagnostics. Another focus is the development, validation and application of miniaturized multiplex sandwich immunoassays in proteomics for pharmaceutical and clinical applications. A special focus is also on developments in the field of personalized medicine. Dr. Schneiderhan-Marra has been at the NMI since 2005 and is currently head of the Pharma and Biotech Division.

Selected publications

• Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron Variants. Clinical Infectious Disease, 2023, DOI: 10.1093498.
• Exploring beyond clinical routine SARS-CoV-2 serology using MultiCoV-Ab to evaluate endemic coronavirus cross-reactivity. Nature Communications, 2021, DOI: 10.1038/s41467
• Analytical performance of 17 commercially available point-of-care tests for CRP to support patient management at lower levels of the health system. PLoS One, 2023, DOI: 10.13710267
• Borrelia multiplex: a bead-based multiplex assay for the simultaneous detection of Borrelia specific IgG/IgM class antibodies. BMC Infect Dis., 2022, DOI: 10.1186/-07863-9
• CSF and Serum Levels of Inflammatory Markers in PD: Sparse Correlation, Sex Differences and Association With Neurodegenerative Biomarkers. Front Neurol., 2022, DOI: 10.3389/2022.834580
• Study of the Humoral Immune Response towards HCV Genotype 4 Using a Bead-Based Multiplex Serological Assay. High Throughput, 2017, DOI: 10.33906040015

ORCID: 0000-0001-6785-181X